| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | MMED | United States | $14.01 | $0.00 | Strong Buy | 10 | 2026 |
#2 | EQT | United States | $59.70 | $8,644,211,000.00 | Buy | 22 | 1994 |
#3 | TMDX | United States | $100.56 | $605,494,000.00 | Buy | 9 | 2019 |
#4 | FAF | United States | $58.23 | $7,452,200,000.00 | Buy | 4 | 2009 |
#5 | IREN | Australia | $34.70 | $501,023,000.00 | Buy | 11 | 2021 |
#6 | PACS | United States | $32.14 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#7 | TTMI | United States | $97.48 | $2,906,345,000.00 | Strong Buy | 4 | 2000 |
#8 | EYE | United States | $23.69 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#9 | AORT | United States | $34.20 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#10 | AMRX | United States | $12.48 | $0.00 | Strong Buy | 4 | 2018 |
#11 | CALX | United States | $46.34 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#12 | WLDN | United States | $80.34 | $273,352,000.00 | Strong Buy | 4 | 2006 |
#13 | IPGP | United States | $113.94 | $1,003,777,000.00 | Strong Buy | 5 | 2000 |
#14 | HNRG | United States | $15.83 | $469,466,000.00 | Strong Buy | 4 | 1995 |
#15 | WGO | United States | $30.36 | $1,985,674,000.00 | Buy | 11 | 1994 |
#16 | WBD | United States | $27.32 | $0.00 | Buy | 21 | 2008 |
#17 | WRBY | United States | $20.28 | $871,905,000.00 | Buy | 13 | 2021 |
#18 | ICUI | United States | $123.31 | $2,231,262,000.00 | Buy | 5 | 1995 |
#19 | CTRE | United States | $38.32 | $476,393,000.00 | Buy | 10 | 2013 |
#20 | STOK | United States | $32.74 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#21 | ANAB | United States | $57.68 | $234,603,000.00 | Buy | 11 | 2015 |
#22 | APH | United States | $128.00 | $0.00 | Strong Buy | 12 | 1994 |
#23 | MRCY | United States | $74.22 | $912,020,000.00 | Buy | 7 | 1997 |
#24 | WING | United States | $153.22 | $696,853,000.00 | Strong Buy | 27 | 2015 |
#25 | LASR | United States | $60.12 | $191,359,000.00 | Strong Buy | 9 | 2018 |
#26 | PM | United States | $158.10 | $40,648,000,000.00 | Strong Buy | 9 | 2007 |
#27 | ARVN | United States | $10.85 | $262,600,000.00 | Buy | 20 | 2018 |
#28 | BSX | United States | $62.82 | $9,076,000,000.00 | Strong Buy | 21 | 2010 |
#29 | HCSG | United States | $18.35 | $1,837,173,000.00 | Buy | 6 | 1994 |
#30 | DXCM | United States | $62.22 | $0.00 | Strong Buy | 21 | 2005 |
#31 | KDP | United States | $25.31 | $16,603,000,000.00 | Buy | 16 | 2007 |
#32 | RRX | United States | $183.99 | $3,257,100,000.00 | Buy | 10 | 1994 |
#33 | ACM | United States | $84.71 | $16,139,622,000.00 | Strong Buy | 10 | 2007 |
#34 | ESTA | United States | $58.31 | $61,208,000.00 | Strong Buy | 7 | 2018 |
#35 | ROAD | United States | $105.89 | $785,679,000.00 | Strong Buy | 5 | 2018 |
#36 | RTX | United States | $195.78 | $80,738,000,000.00 | Buy | 12 | 1994 |
#37 | UHS | United States | $176.70 | $17,364,829,000.00 | Buy | 11 | 1994 |
#38 | AMBA | United States | $50.54 | $295,402,000.00 | Strong Buy | 9 | 2011 |
#39 | SWK | United States | $68.64 | $15,130,400,000.00 | Buy | 9 | 2009 |
#40 | MVBF | United States | $24.85 | $3,400,000.00 | Strong Buy | 5 | 2004 |
#41 | DG | United States | $119.75 | $42,724,369,000.00 | Buy | 22 | 2008 |
#42 | SBH | United States | $13.29 | $3,701,424,000.00 | Buy | 6 | 2006 |
#43 | CLFD | United States | $26.61 | $85,034,000.00 | Strong Buy | 4 | 1995 |
#44 | MDT | Ireland | $86.40 | $33,537,000,000.00 | Buy | 20 | 2014 |
#45 | CHD | United States | $92.85 | $6,203,200,000.00 | Buy | 17 | 2014 |
#46 | CHEF | United States | $57.59 | $1,301,520,000.00 | Strong Buy | 6 | 2011 |
#47 | COCO | United States | $48.24 | $0.00 | Buy | 9 | 2021 |
#48 | OHI | United States | $45.00 | $1,190,099,000.00 | Buy | 10 | 2001 |
#49 | CHRW | United States | $167.84 | $14,869,380,000.00 | Buy | 21 | 1997 |
#50 | ZWS | United States | $45.02 | $1,530,500,000.00 | Buy | 6 | 2008 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $200 to Buy (April 3, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.